VACCINE SHORTAGE, 3rd WAVE ON THE ANVIL, DEMAND FOR PRICE RISE,
There are a few aspects to be considered before the Vaccine Manufacturers are Accused for Profiteering.
First of all let us feel Grateful for the Bold Ventures of the 2 Manufacturers. At that time of making the decision (late 2020), there was NO guarantee for a market as the product was totally a new one, and the Virus too Scientists yet to make a Break through, efficacy yet to be established, trials not conducted. But made it available, first Covishield (as SII completed all 3 phases of trials almost a month before the 2nd ). That was the time when THE NEED FOR Vaccination was slowly being felt to prevent the Infection. When the grievous attack of the 2nd wave started, VACCINATION was considered the last Hope as neither majority of the population followed SAFE BEHAVIOUR well professed by authorities; nor did the administration was strict fully to take adequate effective measures.
From the Government’s side, it had rightly allocated Rs.32,000 Crores for Vaccination for the FY 21- 22. Then there was delay in releasing the funds – do not know for what reason and then allowed exports and allowed the Price rise of Vaccines. Some vaccines imported had even crossed the Rs. 1000 mark for a single dose. Then the domestic Vaccines were also increased from mere Rs. 250 per dose for the paying Patients (Even for the paying patients the Government should not have raised from this level). Instead could have well planned to satisfy all sections and particularly served the Population by vaccinating. It is yet not late ,
* 40-50% of the 70-75 % Target of the population to be Vaccinated TOTALLY FREE – To be procured at the rate of Rs. 150 /dose from Indian Manufacturers (BY MANUFACTURING AT RS. 150/ THE 2 MANUFACTURERS ARE NOT DOING CHARITY – FAIRLY WELL EARMARKED MARGIN OF PROFIT IS INCLUDED ).
* 25% to Private patients (Charge Rs.250 – 300 per dose)
% 25 % for Export.
The above 50 + 25 % of Vaccine dosed for domestic use need to talk about the prices in Indian Rupees and not at all in International currencies (as the value of Indian rupee for example not strong $ - 73, £ - 103, € - 89 Vs Indian currency)
SO IT IS NOT FAIR FOR THE 2 COMPANIES ADVERTISING REPEATEDLY THAT THEIR VACCINES ARE THE CHEAPEST IN THE WORLD.
The 2 companies have got this Golden Opportunity to be Pioneers from The Great country to start manufacture of Corona Vaccine – So they need not follow the philosophy of “Disasters are a fabulous business,” or “Make Hay while sunshine” – The 2 companies will make money as the number of Vaccine doses required will be huge . more